Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q2 2016 · 10-Q
Revenue$176.00K$176.00K−35.5% vs Q2 2015 Net Income-$10.90M-$10.90MN/M vs Q2 2015 EPS Diluted-$0.19-$0.19N/M vs Q2 2015 Operating Income-$2,259,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-1283.5%−647.6 pt vs Q2 2015
Net margin-6194.3%−5558.4 pt vs Q2 2015
ended Jan 31, 2016 · filed Mar 9, 2016 · 38 d after period end